Posted On: 10/10/2013 7:22:27 AM
Post# of 72446
Plenty for shareholders to feel good about in this update 
But most importantly :
But most importantly :
Increase to 110mg/m2 for cohort 6
Great update all around! 3 INDs on 2 products now on the way over the next few months, therapeutics partnership conference coming up soon, onward and upward at Dana Farber, financing leads being pursued by CEO, and ongoing research continues to hum along quietly on K that should lead to more trials. As a shareholder , I couldn't be more pleased with all of the progress being made on every front.
Good progress on all fronts, except the SP, which will catch up in time.
Great update all around! 3 INDs on 2 products now on the way over the next few months, therapeutics partnership conference coming up soon, onward and upward at Dana Farber, financing leads being pursued by CEO, and ongoing research continues to hum along quietly on K that should lead to more trials. As a shareholder , I couldn't be more pleased with all of the progress being made on every front.
Good progress on all fronts, except the SP, which will catch up in time.
(0)
(0)
